论文部分内容阅读
目的:评价乳腺钼靶立体定位Mammotome微创活检的临床应用。方法:对196例以钼靶发现钙化为主要临床表现的研究对象,在局麻下进行钙化灶的乳腺钼靶立体定位Mammotome微创活检,病理结果为恶性或可疑恶性的病例接受手术活检。对两者结果进行比较。并对研究对象进行随访。结果:196例经Mammotome微创活检病理结果乳腺病或纤维腺瘤145例,导管内癌(DCIS)20例,导管上皮不典型增生11例,浸润性癌9例,导管内癌伴早期浸润8例,乳腺炎症1例,脂肪坏死1例,不能诊断1例。病理符合率浸润性癌为88.9%,DCIS伴早期浸润为62.5%,DCIS为80.0%,不典型增生为81.8%。结论:乳腺钼靶立体定位Mammotome微创活检操作简便,定位准确,并发症少,是乳腺钼靶钙化尤其是可疑恶性病灶的首选方法。
Objective: To evaluate the clinical application of Mammotome minimally invasive biopsy of breast mammography. Methods: One hundred and sixty-six patients with calcification as the main clinical manifestations were studied with Mammotome minimally invasive biopsy of breast mammography under local anesthesia. Surgical biopsy was performed in patients with malignant or suspicious malignant pathology. Compare the results of both. The subjects were followed up. Results: 196 cases of Mammotome minimally invasive biopsy results of 145 cases of breast disease or fibroadenoma, ductal carcinoma (DCIS) in 20 cases, ductal dysplasia in 11 cases, invasive carcinoma in 9 cases, ductal carcinoma with early infiltration 8 Cases, 1 case of mastitis, fat necrosis in 1 case, can not be diagnosed in 1 case. Pathological coincidence rate of invasive carcinoma was 88.9%, DCIS with early infiltration was 62.5%, DCIS was 80.0%, dysplasia was 81.8%. Conclusion: Mammotome minimally invasive biopsy of breast mammography is easy to operate, accurate in positioning and less complication. It is the preferred method of breast mammography calcification, especially suspicious malignant lesions.